Patients' experience with information technology in diabetes care

被引:0
作者
Kulzer, B. [1 ,3 ]
Heinemann, L. [2 ]
Roos, Timm [1 ]
机构
[1] Univ Bamberg, Diabet Zentrum Mergentheim, Forsch Inst Diabet, Akad Bad Mergentheim FIDAM, Theodor Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany
[2] Sci Consulting Diabet GmbH, Neuss, Germany
[3] Univ Bamberg, Forsch Inst Diabetes, Akad Bad Mergentheim FIDAM, Bad Mergentheim, Germany
来源
DIABETOLOGE | 2021年 / 17卷 / 03期
关键词
Digital technology; Digital therapies; Technological innovations; Patient perspective; Empowerment;
D O I
10.1007/s11428-021-00753-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We examined the attitudes of people with diabetes toward digitization and advancing technology in diabetology, what advantages and disadvantages they see, and how do they assess current developments in IT (information technology) in diabetology. Materials and methods In all, 3427 people with diabetes completed an online survey. Results Overall, survey participants had a very positive attitude toward digitization (83% positive/very positive) and considered the potential for optimizing diabetology to be very high (79%). The greatest advantages of digitization were "better quality of treatment" (80%), "greater personal responsibility and self-determination in therapy" (80%), and "more support in therapy decisions" (78%), while the greatest disadvantages were the "error-proneness of digital applications" (36%), the "risk of misuse of patient data" (32%) and the "fear that digitization will replace the doctor in many cases" (31%). The possibility of evaluating and analyzing glucose data by means of software, automated insulin delivery (AID) systems, and improving the interoperability of the various applications are currently rated as the most significant topics. Conclusions People with diabetes are very positive about new technologies in diabetology and associate it with high hopes that it will improve and simplify their diabetes therapy and reduce the burdens associated with diabetes. Especially people with type 1 diabetes (or their parents) have high expectations for AID systems to significantly improve treatment of their diabetes.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 14 条
[1]   Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management [J].
Adams, Rebecca N. ;
Tanenbaum, Molly L. ;
Hanes, Sarah J. ;
Ambrosino, Jodie M. ;
Ly, Trang T. ;
Maahs, David M. ;
Naranjo, Diana ;
Walders-Abramson, Natalie ;
Weinzimer, Stuart A. ;
Buckingham, Bruce A. ;
Hood, Korey K. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) :648-653
[2]   Patient-Driven Diabetes Care of the Future in the Technology Era [J].
Ashrafzadeh, Sahar ;
Hamdy, Osama .
CELL METABOLISM, 2019, 29 (03) :564-575
[3]   State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 [J].
Foster, Nicole C. ;
Beck, Roy W. ;
Miller, Kellee M. ;
Clements, Mark A. ;
Rickels, Michael R. ;
DiMeglio, Linda A. ;
Maahs, David M. ;
Tamborlane, William V. ;
Bergenstal, Richard ;
Smith, Elizabeth ;
Olson, Beth A. ;
Garg, Satish K. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (02) :66-72
[4]   Psychology, Technology, and Diabetes Management [J].
Gonder-Frederick, Linda A. ;
Shepard, Jaclyn A. ;
Grabman, Jesse H. ;
Ritterband, Lee M. .
AMERICAN PSYCHOLOGIST, 2016, 71 (07) :577-589
[5]  
Heinemann L, 2021, DIGITALISIERUNGS UND, P150
[6]   Psychosocial aspects of diabetes technology [J].
Kubiak, T. ;
Priesterroth, L. ;
Barnard-Kelly, K. D. .
DIABETIC MEDICINE, 2020, 37 (03) :448-454
[7]  
Kulzer B, 2020, DIGITALISIERUNGS UND
[8]   Diabetes Technology and the Human Factor [J].
Liberman, Alon ;
Barnard, Katharine .
DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 :S138-S147
[9]   HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry Findings [J].
Miller, Kellee M. ;
Beck, Roy W. ;
Foster, Nicole C. ;
Maahs, David M. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (09) :645-650
[10]  
Oberg Ulrika, 2018, JMIR Diabetes, V3, pe7, DOI 10.2196/diabetes.9059